InvestorsHub Logo
Followers 11
Posts 819
Boards Moderated 0
Alias Born 07/24/2015

Re: Money $hot post# 1690

Sunday, 04/23/2017 12:22:13 PM

Sunday, April 23, 2017 12:22:13 PM

Post# of 16695
Yeah, I know... This may seem a bit speculative and off topic. However,

The recent acquisition of Alere (ALR) by healthcare giant Abbott Laboratories (ABT) for $5.3B is a story worth noting.

http://abbott.mediaroom.com/2017-04-14-Abbott-and-Alere-Amend-Terms-of-Merger-Agreement

With changing public sentiment and eminent marijuana legalization in Canada, ABT (with its Boston based research facility) is positioning itself to capitalize on the impending windfall from legalized cannabis by purchasing ALR, makers of alcohol breathalyzers and most importantly portable drug screening devices.

Developing innovations in healthcare diagnostics coupled with renewed investment particularly in "early stage diagnostics" has assembled the perfect environment for advanced technologies and the companies that create them. As testing of our devices (BLO/ZF - BTH/CF) progresses and general awareness increases, interest in our proprietary technologies by the big players in the space will also increase.

Inclusion in the ETF (Emerging AgroSphere Fund) provides BLO/ZF a clear opportunity to spotlight it's advanced FAIMS technology to ABT at a key time when an alternative to traditional/invasive swab testing will be saught.

The fact of the matter is that both BLO/ZF and our sister company BTH/CF is right in Abbott Laboratories wheelhouse.

Food for thought.
These are exciting times...
IMO -